Bexotegrast

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameBexotegrast
Drug Alias NamePLN-74809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-1 inhibitorsIntegrin alpha-V/beta-6 antagonists
TargetsIntegrin alpha-V/beta-1Integrin alpha-V/beta-6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[27] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesIqvia Rds (Shanghai) Co LtdAndersonbrecon Inc
Active IndicationsCholangitis, Sclerosing
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG